India’s largest In-vitro Diagnostic Company, Transasia Bio-Medicals has been ranked as one of the top 500 most valuable companies in India. This annual list was recently released by Hurun India in coordination with Burgundy Private and Axis Bank’s Private Banking Business. Transasia features in the Top 500 list at the #354 position with an estimated value of Rs. 8,900 crore ( approx. USD 1.2 Billion).

“Transasia is honoured to be featured in the 2021 list. We are proud to be recognized and featured alongside so many other inspiring, innovative companies that value a workplace culture built on integrity, trust, and compassion,” cited Suresh Vazirani, Founder Chairman, Transasia-Erba Group of Companies.

In last 42 years, Transasia has pioneered in meeting India’s needs for essential diagnosis through affordable and innovative, Made-in-India for the world products and solutions. Today, Transasia has over 100,000 instruments installed in over 50,000 hospitals and labs across the world and is helping millions of people become healthier and happier in more than 100 countries worldwide.

Through its state of the art R&D centres in India, Europe and USA, Transasia has developed world-class technologies for a wide range of disease diagnosis and solutions in Clinical Chemistry, Hematology, Immunology, Diabetes Management, Urinalysis, Coagulation, Critical Care and Molecular Diagnostics.

Transasia is acknowledged as the undisputed leader in offering the strongest service network in the country, from the largest city to the smallest town with the largest team of over 700+ field staff and 500+ Distributors.

“I extend my sincerest thanks to our 50,000+ customers in India and 100 other countries who have trusted us by offering our diagnostic solutions to their patients for early and accurate diagnosis. I also acknowledge the dedication and commitment of all Transasia-Erba employees based all over the world and also all our partners, distributors and suppliers, across the world,” added Mr. Vazirani.

The companies included in the list of 500 most valuable companies are ranked according to their value, defined as market capitalisation for listed companies and valuations for non-listed companies.